Temporal morphogen-driven neural induction spurs growth of expanded brain organoids with enhanced neuroepithelium formation

Researchers examinea the effects of temporal morphogen gradient during neural induction on the formation of brain organoids.

China NMPA approves KeChow’s tunlametinib for melanoma

Share this article In a Phase II trial in melanoma patients, tunlametinib demonstrated an overall response rate of 35.8%. Credit: Africa Studio / Shutterstock.com. The

March 19, 2024

FDA Approves Blood Test for Colon Cancer Screening

The FDA approved the Shield blood test for colorectal cancer (CRC) screening in adults ages 45 and older at average risk for the disease, Guardant

July 30, 2024

How the brain switches between daydreaming and reality

When we daydream, we must be able to snap back to attention at a moment’s notice. Researchers at Boston Children’s Hospital uncovered how our brains

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.